. This study is an attempt to produce a fusion protein by binding the fragment NT-gp96 in upstream of sequence of the N terminal fragment (NT300) of the NS5B gene in an expression vector.
Amin Ramezani
Advertisement
Amin Ramezani is assistant professor at Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran and the Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
Articles by Amin Ramezani
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Roche, Hansoh Sign Second ADC Pact Covering Preclinical and Roche-Selected Targets
2
Regeneron's Libtayo Earns CHMP Nod for Expanded EU Dosing
3
Lilly’s Omvoh Reaches 50% One-Year Remission in Pediatric Ulcerative Colitis
4
The BioPharm Brief: New Approval, Pediatric Progress, and Durable Remission
5